Up date in the management of advanced ovarian carcinoma.
about
Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data.Inhibition of PI3K/Akt/mTOR signaling pathway enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin in vitro.Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.Dieckol, isolated from the edible brown algae Ecklonia cava, induces apoptosis of ovarian cancer cells and inhibits tumor xenograft growth.High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).
P2860
Up date in the management of advanced ovarian carcinoma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Up date in the management of advanced ovarian carcinoma.
@ast
Up date in the management of advanced ovarian carcinoma.
@en
type
label
Up date in the management of advanced ovarian carcinoma.
@ast
Up date in the management of advanced ovarian carcinoma.
@en
prefLabel
Up date in the management of advanced ovarian carcinoma.
@ast
Up date in the management of advanced ovarian carcinoma.
@en
P2093
P1476
Up date in the management of advanced ovarian carcinoma.
@en
P2093
P356
10.1016/S1040-8428(99)00036-0
P577
1999-09-01T00:00:00Z